.Nature Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view calls for inclusion of individuals with MASLD and also measurement of liver results in cardio-- renal-- metabolic trials, when data suggest mechanistically possible benefits as well as professional safety-- and also lays out points to consider for trial layout and also regulatory approval.